Tüm alıştırma soruları

8270 soru

Soru 4561Soru →

A 2-month-old girl is brought to the pediatrician by her parents for her first routine well-child visit. She was born at 39 weeks gestation via an uncomplicated spontaneous vaginal delivery. Her mother has a history of severe Crohn disease, which has been well controlled with infliximab therapy. The mother received scheduled infliximab infusions throughout her pregnancy, with the final dose administered 3 weeks prior to delivery. The infant is exclusively breastfed and is gaining weight appropriately. Physical examination reveals an alert, active infant with normal vital signs and no abnormalities. In addition to the second dose of the hepatitis B vaccine, the infant is due for her first doses of the diphtheria, tetanus, and acellular pertussis (DTaP), Haemophilus influenzae type b (Hib), inactivated polio (IPV), pneumococcal conjugate (PCV15), and rotavirus vaccines. Which of the following is the most appropriate recommendation regarding this patient's immunizations today?

Cevabı ve açıklamayı göster

Cevap: Administer all scheduled inactivated vaccines; withhold the rotavirus vaccine entirely

Cevap

Administer all scheduled inactivated vaccines; withhold the rotavirus vaccine entirely.
Infliximab is an IgG1 monoclonal antibody targeting TNF-alpha. Like other maternal IgG antibodies, it actively crosses the placenta, primarily during the third trimester. Infants born to mothers receiving infliximab can have detectable, immunosuppressive serum levels of the drug for up to 6 months after birth. Because of the risk of severe, disseminated infection in an immunocompromised host, all live-attenuated vaccines (including the oral rotavirus vaccine) are contraindicated in these infants during their first 6 months of life. Therefore, the rotavirus vaccine must be withheld. However, all inactivated, toxoid, and recombinant vaccines (such as DTaP, Hib, IPV, PCV15, and HepB) are completely safe, carry no risk of vaccine-strain infection, and should be administered according to the routine schedule to ensure timely protection.

Adım Adım Çözüm

1
Identify the maternal medication and its mechanism of action.
The mother is taking infliximab, an IgG1 monoclonal antibody against TNF-alpha.
To understand the potential immunological risk to the fetus and infant.
2
Determine the extent of placental transfer of the medication.
Maternal IgG antibodies actively cross the placenta, especially during the third trimester, leading to significant serum levels of infliximab in the infant that can persist for up to 6 months.
To assess if the infant is systematically exposed and potentially immunosuppressed.
3
Identify the nature of the scheduled vaccines.
Rotavirus is a live-attenuated oral vaccine. DTaP, Hib, IPV, PCV15, and HepB are inactivated, toxoid, or recombinant vaccines.
Different vaccine types have fundamentally different safety profiles in immunocompromised hosts.
4
Apply immunization guidelines for infants exposed to maternal biologics in utero.
Live vaccines (rotavirus) are contraindicated for the first 6 months of life. Inactivated vaccines should be given on the normal schedule. Because the rotavirus vaccine series cannot be initiated after 14 weeks and 6 days, this infant will age out of eligibility and must skip the rotavirus series entirely.
To provide safe and effective preventive care while adhering to established contraindications.

Anahtar Kavram

Live-attenuated vaccines, such as rotavirus, are contraindicated for the first 6 months of life in infants exposed in utero to maternal biologic response modifiers (e.g., TNF-alpha inhibitors) due to the risk of disseminated vaccine-strain infection.
Tahmini Süre:1m 15s
Soru 4562Soru →

A 26-year-old woman, G1P0, at 16 weeks gestation is evaluated during a routine prenatal visit. She reports mild fatigue over the past month but is otherwise feeling well. She has no significant past medical history. Current medications include a daily prenatal vitamin.

Vital signs are within normal limits. Physical examination reveals normal conjunctivae, no scleral icterus, and a gravid uterus consistent with gestational age.

Laboratory results are as follows:

TestResultReference Range
Hemoglobin10.1 g/dL10.1\text{ g/dL}12.0−15.5 g/dL12.0-15.5\text{ g/dL}
Mean corpuscular volume (MCV)65 fL65\text{ fL}80−100 fL80-100\text{ fL}
Red blood cell (RBC) count5.8 million/μL5.8\text{ million/}\mu\text{L}4.1−5.1 million/μL4.1-5.1\text{ million/}\mu\text{L}
Platelets250,000/μL250,000\text{/}\mu\text{L}150,000−400,000/μL150,000-400,000\text{/}\mu\text{L}
Leukocytes8,500/μL8,500\text{/}\mu\text{L}4,500−11,000/μL4,500-11,000\text{/}\mu\text{L}
Serum iron95 μg/dL95\text{ }\mu\text{g/dL}60−170 μg/dL60-170\text{ }\mu\text{g/dL}
Total iron-binding capacity (TIBC)310 μg/dL310\text{ }\mu\text{g/dL}240−450 μg/dL240-450\text{ }\mu\text{g/dL}
Ferritin180 ng/mL180\text{ ng/mL}12−150 ng/mL12-150\text{ ng/mL}

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Hemoglobin electrophoresis

Cevap

The most appropriate next step is to perform hemoglobin electrophoresis to evaluate for thalassemia trait.
The patient presents with a profoundly microcytic anemia (MCV 65 fL) but has normal iron studies, including a ferritin level of 180 ng/mL, which effectively rules out iron deficiency. Furthermore, her red blood cell (RBC) count is elevated despite the low hemoglobin, yielding a Mentzer index (MCV/RBC count) of less than 13. This combination of severe microcytosis, an elevated RBC count, and normal to high iron stores is the classic presentation of thalassemia minor (trait). The definitive next step in management to confirm this diagnosis is hemoglobin electrophoresis, which typically demonstrates an elevated hemoglobin A2 fraction in beta-thalassemia trait.

Adım Adım Çözüm

1
Analyze the complete blood count (CBC) results.
The patient has mild anemia (Hemoglobin 10.1 g/dL) with profound microcytosis (MCV 65 fL) and an elevated RBC count (5.8 million/µL).
To classify the morphology of the anemia based on red blood cell indices.
2
Evaluate the iron panel to distinguish the etiology of the microcytosis.
Serum iron, TIBC, and ferritin are all within or slightly above normal limits.
To rule out iron deficiency, which is the most common cause of microcytic anemia in pregnancy.
3
Synthesize findings to determine the most likely diagnosis.
Microcytic anemia with normal iron stores and an elevated RBC count (yielding a Mentzer index < 13) strongly suggests thalassemia minor (trait).
Differentiating between causes of microcytosis directs the next diagnostic or therapeutic step.
4
Select the appropriate diagnostic confirmation test.
Hemoglobin electrophoresis is indicated.
Electrophoresis separates hemoglobins and identifies abnormal variants or altered proportions (e.g., elevated HbA2 in beta-thalassemia trait).

Anahtar Kavram

Patients presenting with microcytic anemia, an elevated red blood cell count, and normal iron studies (normal or elevated ferritin) should be evaluated for thalassemia trait using hemoglobin electrophoresis.
Soru 4563Soru →

For each distinct laboratory and clinical profile in patients presenting with bleeding symptoms, match the most accurate underlying diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Prolonged activated partial thromboplastin time (aPTT) that corrects with a mixing study, normal prothrombin time (PT), and normal platelet count in a male with recurrent hemarthrosis.
Prolonged PT, prolonged aPTT, decreased fibrinogen, elevated D-dimer, and thrombocytopenia in a patient with gram-negative bacteremia.
Isolated prolonged PT, normal aPTT, and normal platelet count in a patient with a history of recurrent mild epistaxis.
Prolonged bleeding time, prolonged aPTT, normal PT, and normal platelet count in a female with heavy menstrual bleeding.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches logically connect specific patterns of intrinsic, extrinsic, and common pathway coagulation defects with their classic hematologic disorders.
Each coagulation profile maps directly to a specific physiological part of the hemostatic pathway. Isolated correctable aPTT prolongation implies an intrinsic factor deficiency. Global cascade prolongation with thrombocytopenia indicates consumptive coagulopathy. Isolated PT prolongation zeroes in on the extrinsic pathway. Combined aPTT and bleeding time prolongation indicates concurrent primary and secondary hemostatic defects.

Adım Adım Çözüm

1
Analyze the first profile showing isolated aPTT prolongation that corrects with a mixing study.
Points to an intrinsic pathway factor deficiency (Hemophilia).
A mixing study correction rules out autoantibodies (inhibitors), identifying a pure factor deficiency in the intrinsic cascade (Factor VIII, IX, XI, or XII).
2
Evaluate the second profile demonstrating global coagulation failure with thrombocytopenia.
Corresponds to a consumptive coagulopathy (DIC).
Sepsis triggers widespread tissue factor release, simultaneously consuming clotting factors and platelets while activating fibrinolysis.
3
Examine the third profile characterized by an isolated PT prolongation.
Indicates an isolated extrinsic pathway defect.
Factor VII is uniquely responsible for the extrinsic pathway; an isolated deficiency will only prolong the PT without affecting the aPTT or bleeding time.
4
Assess the fourth profile featuring combined primary (bleeding time) and secondary (aPTT) hemostasis defects.
Identifies von Willebrand disease.
vWF mediates initial platelet adhesion (primary hemostasis) and stabilizes Factor VIII in the plasma (secondary hemostasis), leading to this dual laboratory abnormality.

Anahtar Kavram

Interpretation of coagulation panels and platelet counts to diagnose inherited and acquired bleeding disorders.
Tahmini Süre:1m 30s
Soru 4564Soru →

A 65-year-old woman is hospitalized due to a 2-day history of high fever, right-sided flank pain, and altered mental status. She has a history of poorly controlled type 2 diabetes mellitus and recurrent urinary tract infections. On admission, her temperature is 39.2°C (102.6°F), blood pressure is 88/56 mm Hg, pulse is 118/min, and respirations are 22/min. Physical examination is notable for severe right costovertebral angle tenderness. Laboratory studies show a leukocyte count of 18,500/mm³. Urinalysis is positive for leukocyte esterase, nitrites, and numerous leukocytes. Blood and urine cultures are obtained, and the patient is started on empiric intravenous piperacillin-tazobactam. Over the next 48 hours, her fever resolves, and her hemodynamics normalize.

Preliminary results from both blood and urine cultures grow *Enterobacter cloacae*. Antimicrobial susceptibility testing reveals the isolate is susceptible to ceftriaxone, cefepime, piperacillin-tazobactam, meropenem, and gentamicin. It is resistant to ciprofloxacin and trimethoprim-sulfamethoxazole. Which of the following is the most appropriate next step in antimicrobial therapy?

Cevabı ve açıklamayı göster

Cevap: Switch to intravenous cefepime

Cevap

The most appropriate step is to switch the patient's therapy to intravenous cefepime.
The correct approach for treating invasive infections (e.g., bacteremia) caused by organisms with a high risk of clinically significant AmpC beta-lactamase production (such as *Enterobacter cloacae*, *Klebsiella aerogenes*, and *Citrobacter freundii*) is to use a fourth-generation cephalosporin, such as cefepime. Cefepime is highly stable against AmpC hydrolysis and is a weak inducer of the enzyme. Although carbapenems (like meropenem) are also highly effective, antimicrobial stewardship guidelines strongly recommend cefepime as a carbapenem-sparing targeted therapy for susceptible AmpC isolates.

Adım Adım Çözüm

1
Identify the pathogen and its specific intrinsic resistance mechanisms.
The pathogen is *Enterobacter cloacae*, a classic organism known to harbor an inducible chromosomal AmpC beta-lactamase gene.
Recognizing the intrinsic resistance mechanisms of specific organisms is essential for safely interpreting laboratory susceptibility reports.
2
Interpret the susceptibility results in the context of the pathogen's AmpC production risk.
Although ceftriaxone and piperacillin-tazobactam show in vitro susceptibility, third-generation cephalosporins are strong inducers of AmpC and can lead to rapid hyperproduction and clinical failure in vivo.
In vitro susceptibility does not always guarantee in vivo clinical success, particularly with inducible beta-lactamase producers.
3
Select the optimal targeted therapy by balancing clinical efficacy and antimicrobial stewardship.
Cefepime, a fourth-generation cephalosporin, is highly stable against AmpC hydrolysis and is a weak inducer, making it the drug of choice. Meropenem is effective but should be reserved for cases where cefepime cannot be used.
Cefepime provides definitive, targeted therapy for invasive AmpC infections while adhering to stewardship principles by sparing overly broad-spectrum agents like carbapenems.

Anahtar Kavram

Management of invasive infections caused by moderate-to-high risk AmpC beta-lactamase-producing organisms (e.g., *Enterobacter cloacae*) requires avoiding third-generation cephalosporins despite in vitro susceptibility; cefepime is the preferred definitive therapy.
Soru 4565Soru →

Match each clinical scenario involving the use of a rheumatologic medication to its most critical associated toxicity, pharmacological interaction, or pre-treatment screening requirement.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient with established rheumatoid arthritis begins treatment with a pyrimidine synthesis inhibitor. Months later, she decides to pursue pregnancy, necessitating an accelerated drug elimination protocol.
An individual diagnosed with granulomatosis with polyangiitis is scheduled to receive a chimeric monoclonal antibody targeting CD20 to induce disease remission.
A patient with a history of recurrent gouty arthritis managed with daily allopurinol is evaluated for the addition of a purine analog immunosuppressant.
A recently diagnosed patient with systemic lupus erythematosus starts a cornerstone antimalarial therapy known to reduce disease flares and improve long-term survival.
A patient with severe rheumatoid arthritis is treated with a biologic therapy targeting tumor necrosis factor alpha. Several months later, the patient develops a chronic cough, night sweats, and apical lung cavitations.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matching pairs are: Leflunomide with teratogenicity requiring cholestyramine washout; Rituximab with hepatitis B reactivation risk; Azathioprine with life-threatening pancytopenia risk when combined with allopurinol; Hydroxychloroquine with irreversible retinal toxicity risk; and TNF-alpha inhibitors with latent tuberculosis reactivation risk.
Each rheumatologic medication possesses a highly specific toxicity profile and mechanism of action that dictates its clinical management. Leflunomide requires a cholestyramine washout for pregnancy due to its long half-life. Rituximab profoundly depletes B cells, risking severe viral reactivation like HBV. Azathioprine metabolism is directly blocked by allopurinol, leading to severe pancytopenia. Hydroxychloroquine causes dose-dependent retinal toxicity requiring specialized OCT screening. Lastly, TNF-alpha inhibitors disrupt maintaining granulomas, necessitating screening for latent tuberculosis.

Adım Adım Çözüm

1
Identify the pyrimidine synthesis inhibitor (leflunomide) and its specific pharmacokinetic property.
Leflunomide undergoes enterohepatic circulation causing a long half-life and is teratogenic, matching the need for cholestyramine washout.
Cholestyramine interrupts enterohepatic circulation, allowing safe drug elimination before pregnancy.
2
Identify the anti-CD20 monoclonal antibody (rituximab) and its infectious risks.
Rituximab causes profound B-cell depletion, matching the risk for hepatitis B reactivation and progressive multifocal leukoencephalopathy.
B cells are necessary for controlling certain latent viral infections.
3
Identify the purine analog (azathioprine) and its interaction with the patient's existing gout medication (allopurinol).
Allopurinol blocks xanthine oxidase, matching the risk of toxic azathioprine metabolite accumulation and fatal pancytopenia.
Xanthine oxidase is required to safely degrade 6-mercaptopurine (the active metabolite of azathioprine).
4
Identify the antimalarial agent (hydroxychloroquine) and its long-term monitoring requirements.
Hydroxychloroquine accumulates in melanin-rich tissues, matching the risk of bull's-eye maculopathy and the need for regular OCT screening.
Early detection of retinal toxicity prevents irreversible vision loss.
5
Identify the biologic agent causing apical lung cavitations (TNF-alpha inhibitor) and its pre-treatment requirement.
TNF-alpha inhibitors disrupt granulomas, matching the risk of tuberculosis reactivation and the need for IGRA screening.
TNF-alpha is essential for maintaining the granulomas that keep mycobacterial infections in a latent state.

Anahtar Kavram

Adverse effects, drug interactions, and pre-treatment screening requirements for disease-modifying antirheumatic drugs (DMARDs) and biologic agents.
Soru 4566Soru →

An internal medicine clinical pathways committee is updating hospital protocols for the acute management of oncologic complications. Match each of the following patient presentations—characterized by specific clinical signs, symptoms, and targeted laboratory data—to the single most appropriate initial therapeutic intervention according to current clinical guidelines.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 69-year-old man with metastatic prostate cancer who presents with rapidly progressive bilateral lower extremity weakness, a distinct sensory deficit below the umbilicus, and new-onset urinary retention.
A 41-year-old woman undergoing induction chemotherapy for acute myeloid leukemia who develops oliguria, an electrocardiogram demonstrating peaked T waves, and laboratory studies revealing severe hyperuricemia and low serum calcium.
A 61-year-old woman with advanced breast cancer who presents with profound lethargy, severe constipation, an abbreviated QT interval on electrocardiography, and a serum calcium level of 14.6 mg/dL14.6\text{ mg/dL}.
A 54-year-old man receiving systemic chemotherapy who presents with a temperature of 39.4∘C39.4^\circ\text{C} (102.9∘F102.9^\circ\text{F}), no focal infectious symptoms on examination, and an absolute neutrophil count of 300/μL300/\mu\text{L}.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches pair each oncologic emergency with its definitive initial management: malignant spinal cord compression requires immediate glucocorticoids; tumor lysis syndrome requires fluids and rasburicase; severe hypercalcemia requires aggressive saline followed by bisphosphonates; and febrile neutropenia requires immediate empiric antipseudomonal antibiotics.
The correct matches represent the consensus guidelines for acute oncologic emergencies. Suspected malignant spinal cord compression necessitates immediate corticosteroids to mitigate permanent neurologic damage. Tumor lysis syndrome requires vigorous hydration and rasburicase to address hyperuricemia and preserve renal function. Severe hypercalcemia requires initial aggressive isotonic saline to correct profound volume depletion before bisphosphonates take effect. Febrile neutropenia demands immediate blood cultures and the empiric initiation of an antipseudomonal beta-lactam to prevent fulminant sepsis.

Adım Adım Çözüm

1
Analyze the first clinical presentation featuring progressive lower extremity weakness, a sensory level, and urinary retention in a patient with prostate cancer.
Identify the condition as malignant spinal cord compression (MSCC).
These findings represent a neurologic emergency requiring immediate intervention to prevent irreversible paralysis.
2
Determine the initial pharmacological step for malignant spinal cord compression.
Match with 'Immediate administration of high-dose intravenous glucocorticoids'.
Corticosteroids rapidly decrease spinal cord edema, relieving pressure while awaiting definitive imaging (MRI) and surgical or radiotherapeutic management.
3
Analyze the second presentation involving oliguria, peaked T waves, hyperuricemia, and hypocalcemia following chemotherapy.
Identify the condition as tumor lysis syndrome (TLS).
Massive tumor cell death releases intracellular contents (potassium, phosphate, and nucleic acids which convert to uric acid) into the bloodstream, precipitating acute kidney injury.
4
Determine the appropriate management for established tumor lysis syndrome.
Match with 'Continuous telemetry, aggressive isotonic fluid resuscitation, and administration of rasburicase'.
Aggressive fluid hydration maintains urine output, telemetry monitors hyperkalemia-induced arrhythmias, and rasburicase enzymatically degrades uric acid to prevent renal tubule crystallization.
5
Analyze the third presentation marked by lethargy, constipation, short QT interval, and calcium > 14 mg/dL.
Identify severe hypercalcemia of malignancy.
Symptoms of severe hypercalcemia typically emerge at levels above 14 mg/dL and induce profound intravascular volume depletion via nephrogenic diabetes insipidus.
6
Select the initial management for severe hypercalcemia of malignancy.
Match with 'Rapid volume expansion with intravenous 0.9% saline and subsequent administration of zoledronic acid'.
Restoration of intravascular volume with normal saline is always the first step, subsequently paired with bisphosphonates to inhibit osteoclastic bone resorption.
7
Analyze the fourth presentation showing fever in the setting of severe chemotherapy-induced neutropenia without a focal source.
Identify febrile neutropenia.
An absolute neutrophil count < 500/μL combined with fever is a life-threatening immunologic emergency where typical signs of focal infection are often absent.
8
Identify the mandatory initial intervention for febrile neutropenia.
Match with 'Immediate procurement of blood cultures followed by prompt initiation of an antipseudomonal beta-lactam'.
Empiric antibiotics must be started within 60 minutes of presentation due to the high risk of rapid clinical deterioration from uncontained bacterial proliferation, particularly from Pseudomonas aeruginosa.

Anahtar Kavram

Recognition and appropriate initial pharmacological management of acute oncologic emergencies (Malignant Spinal Cord Compression, Tumor Lysis Syndrome, Severe Hypercalcemia, and Febrile Neutropenia).
Tahmini Süre:2m 0s
Soru 4567Soru →

During a routine follow-up at the nephrology clinic, a 42-year-old woman is evaluated for persistent hypokalemia and mild muscle weakness. She has a history of Sjögren syndrome and has had two episodes of calcium phosphate nephrolithiasis in the past five years. She reports no diarrhea, vomiting, or recent dietary changes. Her blood pressure is 118/76 mm Hg. Laboratory studies show:

Serum sodium: 140 mEq/L
Serum potassium: 2.9 mEq/L
Serum chloride: 115 mEq/L
Serum bicarbonate: 15 mEq/L
Blood urea nitrogen: 12 mg/dL
Serum creatinine: 0.8 mg/dL

Urine studies obtained simultaneously show:
Urine sodium: 55 mEq/L
Urine potassium: 25 mEq/L
Urine chloride: 60 mEq/L

What is this patient's urine anion gap in mEq/L? (Provide your answer as a number only)

Cevabı ve açıklamayı göster

Cevap: 20

Cevap

20
The patient has a normal anion gap metabolic acidosis (NAGMA), indicated by a serum anion gap of 10 mEq/L (140−(115+15)140 - (115 + 15)). To evaluate the underlying cause of a NAGMA, the urine anion gap (UAG) is calculated to estimate renal ammonium (NH4+NH_4^+) excretion. The formula is: UAG=(UNa+UK)−UClUAG = (U_{Na} + U_{K}) - U_{Cl}. Using the patient's values: UAG=(55+25)−60=80−60=20UAG = (55 + 25) - 60 = 80 - 60 = 20 mEq/L. In normal physiology and gastrointestinal bicarbonate loss (e.g., diarrhea), the kidneys increase NH4+NH_4^+ production, which is excreted with chloride, resulting in a negative UAG. A positive UAG, as seen in this patient, indicates a failure of the kidneys to excrete adequate acid, which is diagnostic for renal tubular acidosis (RTA). Her history of Sjögren syndrome and calcium phosphate stones further points to Type 1 (distal) RTA.

Adım Adım Çözüm

1
Calculate the serum anion gap.
Serum AG = 140−(115+15)=10140 - (115 + 15) = 10 mEq/L.
Confirms the presence of a normal anion gap metabolic acidosis (NAGMA), prompting the need for a urine anion gap.
2
Set up the urine anion gap formula.
UAG=(UNa+UK)−UClUAG = (U_{Na} + U_{K}) - U_{Cl}
The formula estimates unmeasured urinary ammonium excretion.
3
Insert the provided urine electrolyte values.
UAG=(55+25)−60UAG = (55 + 25) - 60
Accurate substitution of variables is required for the calculation.
4
Perform the final calculation.
80−60=2080 - 60 = 20 mEq/L
Yields the correct numerical answer indicating impaired ammonium excretion.

Anahtar Kavram

The urine anion gap (UAG=UNa+UK−UClUAG = U_{Na} + U_{K} - U_{Cl}) differentiates renal from gastrointestinal causes of normal anion gap metabolic acidosis. A positive value reflects impaired urinary ammonium excretion, characteristic of distal renal tubular acidosis.
Soru 4568Soru →

Match the following laboratory profiles of calcium, phosphorus, and parathyroid hormone (PTH) to the most likely underlying pathophysiologic diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Elevated serum calcium, elevated intact PTH, decreased serum phosphorus, elevated 24-hour urine calcium
Elevated serum calcium, suppressed intact PTH, decreased serum phosphorus, elevated PTHrP
Decreased serum calcium, elevated intact PTH, increased serum phosphorus, increased BUN and creatinine
Elevated serum calcium, normal or mildly elevated intact PTH, low 24-hour urine calcium
Decreased serum calcium, suppressed intact PTH, increased serum phosphorus, normal BUN and creatinine

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

1 -> Primary hyperparathyroidism; 2 -> Humoral hypercalcemia of malignancy; 3 -> Secondary hyperparathyroidism due to chronic kidney disease; 4 -> Familial hypocalciuric hypercalcemia; 5 -> Primary hypoparathyroidism.
Calcium homeostasis is maintained primarily by PTH and Vitamin D. Understanding the negative feedback loops and the specific physiologic effects of PTH (bone resorption, renal calcium reabsorption, and renal phosphate excretion) allows for the logical deduction of the underlying pathology from any given laboratory profile.

Adım Adım Çözüm

1
Analyze the serum calcium and PTH levels to determine if the defect is primarily parathyroid-driven or PTH-independent.
High calcium with high PTH indicates a parathyroid-driven process (or altered calcium sensing). High calcium with low PTH indicates a PTH-independent process (e.g., malignancy). Low calcium with high PTH indicates a secondary response. Low calcium with low PTH indicates primary gland failure.
PTH and calcium normally have an inverse relationship due to negative feedback; parallel changes suggest primary parathyroid pathology.
2
Evaluate the phosphorus and renal function markers to further differentiate the etiologies.
Low phosphorus is expected with high PTH or PTHrP activity. High phosphorus with low calcium suggests either renal failure (if BUN/creatinine are high) or hypoparathyroidism (if renal function is normal).
PTH promotes renal phosphate excretion. In chronic kidney disease, the failing kidneys cannot excrete phosphate, overriding the typical PTH effect.
3
Assess urine calcium to distinguish between primary hyperparathyroidism and familial hypocalciuric hypercalcemia (FHH).
Elevated urine calcium points to primary hyperparathyroidism, whereas low urine calcium points to FHH.
FHH involves a defective calcium-sensing receptor in the kidneys, leading to increased renal calcium reabsorption despite systemic hypercalcemia.

Anahtar Kavram

Interpretation of calcium, phosphorus, and PTH laboratory profiles to diagnose underlying disorders of calcium metabolism.
Tahmini Süre:2m 0s
Soru 4569Soru →

A 24-year-old man is brought to the emergency department by his roommate due to increasing lethargy and confusion over the past 12 hours. The patient has a history of type 1 diabetes mellitus and has not taken his insulin for the past week due to financial constraints. Vital signs show a temperature of 37.1∘37.1^\circ C (98.8∘98.8^\circ F), heart rate of 115/min, blood pressure of 105/68 mm Hg, and a respiratory rate of 28/min with deep, rapid breaths.

Laboratory studies reveal:

TestResult
Serum sodium140 mEq/L
Serum potassium4.8 mEq/L
Serum chloride104 mEq/L
Serum bicarbonate12 mEq/L
Blood glucose480 mg/dL

Which of the following arterial pCO2pCO_2 values would best indicate an appropriate, isolated respiratory compensation for this patient's acid-base disturbance?

Cevabı ve açıklamayı göster

Cevap: 26 mm Hg

Cevap

26 mm Hg
The patient presents with diabetic ketoacidosis, which causes a primary high anion gap metabolic acidosis. To determine if the respiratory compensation (indicated by the patient's deep, rapid Kussmaul respirations) is appropriate and isolated, Winter's formula must be applied: expected pCO2=1.5×[HCO3−]+8±2pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2. With a serum bicarbonate of 1212 mEq/L, the expected pCO2pCO_2 is (1.5×12)+8=18+8=26±2(1.5 \times 12) + 8 = 18 + 8 = 26 \pm 2 mm Hg. Therefore, a value of 2626 mm Hg falls perfectly within this range, indicating an appropriate respiratory compensation without a superimposed secondary acid-base disorder.

Adım Adım Çözüm

1
Identify the primary acid-base disturbance.
The patient has a high anion gap metabolic acidosis secondary to diabetic ketoacidosis (Anion gap = 140 - (104 + 12) = 24).
Understanding the primary disorder dictates which compensatory formula must be used.
2
Select the appropriate formula for respiratory compensation in metabolic acidosis.
Winter's formula: Expected pCO2=1.5×[HCO3−]+8±2pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2.
This is the physiological rule governing how the lungs compensate for a primary metabolic acidosis via Kussmaul respirations.
3
Input the patient's bicarbonate level into the formula and calculate.
Expected pCO2=(1.5×12)+8±2=18+8±2=26±2pCO_2 = (1.5 \times 12) + 8 \pm 2 = 18 + 8 \pm 2 = 26 \pm 2 mm Hg.
Performing the calculation determines the precise range (24 to 28 mm Hg) that defines appropriate compensation.

Anahtar Kavram

In patients with a primary metabolic acidosis, the appropriate respiratory compensation (hyperventilation) must be calculated using Winter's formula: expected pCO2=1.5×[HCO3−]+8±2pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2.
Tahmini Süre:1m 0s
Soru 4570Soru →

A 64-year-old man is evaluated in the intensive care unit for abnormal laboratory findings. He was admitted 2 days ago for severe community-acquired pneumonia complicated by septic shock. He was intubated yesterday for worsening hypoxia and is currently mechanically ventilated. The patient is sedated and receiving a continuous intravenous infusion of norepinephrine. Vital signs show a temperature of 38.4∘C38.4^\circ\text{C} (101.1∘F101.1^\circ\text{F}), blood pressure of 92/58 mm Hg92/58 \text{ mm Hg}, heart rate of 118/min118/\text{min}, and oxygen saturation of 95%95\% on the current ventilator settings.

Laboratory studies:
Serum sodium: 140 mEq/L140 \text{ mEq/L}
Serum potassium: 4.1 mEq/L4.1 \text{ mEq/L}
Serum chloride: 100 mEq/L100 \text{ mEq/L}
Serum bicarbonate: 16 mEq/L16 \text{ mEq/L}
Blood urea nitrogen: 32 mg/dL32 \text{ mg/dL}
Serum creatinine: 1.9 mg/dL1.9 \text{ mg/dL}
Serum lactate: 5.2 mmol/L5.2 \text{ mmol/L} (Normal: 0.5−1.5 mmol/L0.5-1.5 \text{ mmol/L})

Arterial blood gas (on mechanical ventilation):
pH: 7.527.52
PaCO2\text{PaCO}_2: 20 mm Hg20 \text{ mm Hg}
PaO2\text{PaO}_2: 78 mm Hg78 \text{ mm Hg}

Which of the following is the most accurate interpretation of this patient's current acid-base status?

Cevabı ve açıklamayı göster

Cevap: Mixed respiratory alkalosis and high anion gap metabolic acidosis

Cevap

Mixed respiratory alkalosis and high anion gap metabolic acidosis
To accurately determine this patient's acid-base status, one must apply a stepwise mathematical approach. First, observe the pH: at 7.527.52, the patient has alkalemia. Next, find the primary driver of this alkalemia: the PaCO2\text{PaCO}_2 is markedly low at 20 mm Hg20 \text{ mm Hg}, which directly causes alkalemia. This identifies a primary respiratory alkalosis, which in this ICU patient is iatrogenic due to hyperventilation by the mechanical ventilator. Crucially, acid-base analysis does not stop at the pH and PaCO2\text{PaCO}_2; the anion gap (AG) must be calculated for every patient. The formula is AG=Na+−(Cl−+HCO3−)AG = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-). Here, AG=140−(100+16)=24 mEq/LAG = 140 - (100 + 16) = 24 \text{ mEq/L}. A normal AG is 8−12 mEq/L8-12 \text{ mEq/L}. An AG greater than 12 mEq/L12 \text{ mEq/L} definitively proves the presence of an independent, primary high anion gap metabolic acidosis (HAGMA). In this patient, the HAGMA is caused by lactic acidosis secondary to septic shock. Finally, a delta-delta ratio calculation (12/8=1.512 / 8 = 1.5) confirms there is no third simultaneous disorder (like a concurrent normal anion gap acidosis or metabolic alkalosis). Therefore, the patient has two primary, concurrent acid-base disturbances.

Adım Adım Çözüm

1
Analyze the pH to determine the predominant acid-base disorder.
The pH is 7.527.52 (alkalemia).
Identifying whether the patient is overall acidemic or alkalemic points to the primary disorder.
2
Examine the PaCO2\text{PaCO}_2 and HCO3−\text{HCO}_3^- to find the driver of the alkalemia.
The PaCO2\text{PaCO}_2 is 20 mm Hg20 \text{ mm Hg} (low).
A low PaCO2\text{PaCO}_2 causes alkalemia. Therefore, a primary respiratory alkalosis is present, likely due to excessive minute ventilation on the mechanical ventilator.
3
Calculate the serum anion gap (AG).
AG=Na+−(Cl−+HCO3−)=140−(100+16)=24 mEq/LAG = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-) = 140 - (100 + 16) = 24 \text{ mEq/L}.
An AG must always be calculated. A normal AG is 8−12 mEq/L8-12 \text{ mEq/L}. An AG of 24 mEq/L24 \text{ mEq/L} proves the presence of a primary high anion gap metabolic acidosis (HAGMA), driven here by elevated lactate from septic shock.
4
Evaluate the Delta-Delta ratio to check for a third disorder.
ΔAG=24−12=12\Delta AG = 24 - 12 = 12. ΔHCO3−=24−16=8\Delta \text{HCO}_3^- = 24 - 16 = 8. Ratio = 12/8=1.512 / 8 = 1.5.
A ratio between 11 and 22 indicates an isolated HAGMA with no additional normal anion gap metabolic acidosis or metabolic alkalosis. Thus, the final diagnosis is a mixed dual disorder.

Anahtar Kavram

In mixed acid-base disorders, an alkalemic pH driven by a low PaCO2\text{PaCO}_2 defines a primary respiratory alkalosis, while an elevated anion gap definitively establishes the concurrent presence of a primary high anion gap metabolic acidosis.
Soru 4571Soru →

A 54-year-old woman comes to the clinic reporting a 2-month history of progressive weakness, particularly when climbing stairs and brushing her hair. She also notes a new rash on her face and hands. Her medical history is unremarkable, and she takes no medications. Physical examination reveals an erythematous, violaceous rash on her upper eyelids and scaling, erythematous plaques over her metacarpophalangeal and proximal interphalangeal joints. Muscle strength is 3/5 in the proximal upper and lower extremities bilaterally, and 5/5 in the distal extremities. Sensation is intact, and deep tendon reflexes are 2+ bilaterally.

Laboratory results show:
TestResultReference Range
Creatine kinase4,500 U/L30-170 U/L
Thyroid-stimulating hormone2.1 mU/L0.5-5.0 mU/L
Free T41.2 ng/dL0.9-1.7 ng/dL
Antinuclear antibodiesPositiveNegative

The physician diagnoses the patient with dermatomyositis and plans to initiate high-dose oral prednisone. Which of the following is the most appropriate additional step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Screening for an underlying malignancy

Cevap

Screening for an underlying malignancy
The correct answer highlights the strong association between adult-onset dermatomyositis and occult malignancy. Approximately 15% to 25% of adult patients with this autoimmune inflammatory myopathy have an underlying cancer, most commonly involving the ovaries, lungs, pancreas, stomach, or colon. Therefore, comprehensive evaluation must include age-appropriate cancer screening (e.g., colonoscopy, mammography, pelvic examinations) in addition to initiating immunosuppressive therapy such as high-dose glucocorticoids.

Adım Adım Çözüm

1
Analyze the clinical presentation.
The patient has progressive proximal muscle weakness, a heliotrope rash (violaceous rash on upper eyelids), and Gottron papules (erythematous plaques over MCP and PIP joints), alongside elevated creatine kinase.
To establish the diagnosis of dermatomyositis.
2
Identify the known disease associations with this diagnosis in adult patients.
Adult-onset dermatomyositis is strongly associated with underlying occult malignancies (e.g., ovarian, lung, pancreatic, stomach, and colorectal cancers).
To determine the necessary comprehensive evaluation steps beyond symptomatic treatment.
3
Select the appropriate additional management step.
Age-appropriate screening for an underlying malignancy is required.
Because identifying a potential underlying paraneoplastic trigger is critical for patient survival and overall management.

Anahtar Kavram

Adult patients with newly diagnosed dermatomyositis have a significantly increased risk of concurrent malignancy and should undergo age-appropriate cancer screening.
Soru 4572Soru →

A 65-year-old man is admitted to the hospital for acute decompensated heart failure and is treated with aggressive intravenous furosemide. On hospital day 3, his blood pressure is 105/65 mm Hg and heart rate is 92/min. Over the past 24 hours, his urine output has decreased to 400 mL. His serum creatinine rises from a baseline of 1.1 mg/dL to 2.8 mg/dL.

Laboratory studies are obtained to evaluate his acute kidney injury:

Serum chemistry:
Sodium: 136 mEq/L
Potassium: 3.8 mEq/L
Chloride: 98 mEq/L
Bicarbonate: 28 mEq/L
Blood urea nitrogen (BUN): 84 mg/dL
Creatinine: 2.8 mg/dL

Urine chemistry:
Sodium: 70 mEq/L
Urea nitrogen: 420 mg/dL
Creatinine: 56 mg/dL

Because recent loop diuretic administration impairs tubular sodium reabsorption, the fractional excretion of sodium (FENaFE_{Na}) can be misleadingly elevated. Instead, the fractional excretion of urea (FEUreaFE_{Urea}) is preferred to differentiate between prerenal azotemia and intrinsic acute tubular necrosis in this clinical scenario.

Calculate the patient's FEUreaFE_{Urea}. Express your answer as a percentage.

Cevabı ve açıklamayı göster

Cevap: 25

Cevap

25
The correct calculation for FEUreaFE_{Urea} is [(420×2.8)/(84×56)]×100=25%[(420 \times 2.8) / (84 \times 56)] \times 100 = 25\%. In the evaluation of acute kidney injury, establishing whether the etiology is prerenal (decreased perfusion) or intrinsic (tubular damage) is critical. While the fractional excretion of sodium (FENaFE_{Na}) is standard, loop diuretics like furosemide block the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle, forcibly wasting sodium into the urine. This often results in an FENa>1%FE_{Na} > 1\% (in this patient, roughly 2.6%), which falsely points toward intrinsic damage. Because urea reabsorption occurs primarily in the proximal tubule and is largely unaffected by loop diuretics, FEUreaFE_{Urea} remains a highly sensitive and specific metric. An FEUreaFE_{Urea} less than 35% strongly confirms a prerenal state driven by severe heart failure and aggressive diuresis.

Adım Adım Çözüm

1
Identify the correct formula for the Fractional Excretion of Urea (FEUrea).
FEUrea=(UrineUrea×SerumCrSerumBUN×UrineCr)×100FE_{Urea} = \left( \frac{Urine_{Urea} \times Serum_{Cr}}{Serum_{BUN} \times Urine_{Cr}} \right) \times 100
This formula standardizes urea clearance against creatinine clearance to assess proximal tubular handling of urea independent of sodium.
2
Extract the relevant variables from the provided laboratory data.
Urine Urea Nitrogen = 420 mg/dL; Serum Creatinine = 2.8 mg/dL; Serum BUN = 84 mg/dL; Urine Creatinine = 56 mg/dL.
Accurate identification is required to avoid incorrectly mixing serum and urine values during calculation.
3
Calculate the numerator by multiplying Urine Urea by Serum Creatinine.
420×2.8=1176420 \times 2.8 = 1176
This represents the relative amount of urea excreted compared to the serum creatinine level.
4
Calculate the denominator by multiplying Serum BUN by Urine Creatinine.
84×56=470484 \times 56 = 4704
This represents the filtered load based on serum BUN normalized by the urine creatinine level.
5
Divide the numerator by the denominator and multiply by 100.
(1176/4704)×100=0.25×100=25%(1176 / 4704) \times 100 = 0.25 \times 100 = 25\%
This calculation yields the final percentage of filtered urea that is actually excreted by the kidneys.

Anahtar Kavram

Fractional Excretion of Urea (FEUrea) is a more reliable marker than FENa for differentiating prerenal azotemia from intrinsic acute tubular necrosis in patients actively receiving loop diuretics.
Soru 4573Soru →

A 36-year-old man with a history of advanced, untreated HIV infection (CD4 count 28 cells/mm328 \text{ cells/mm}^3) is brought to the emergency department due to progressive confusion, severe headaches, and left-sided weakness over the past week. His temperature is 38.1∘C38.1^\circ\text{C} (100.6∘F100.6^\circ\text{F}). Neurologic examination reveals a dense left hemiparesis. MRI of the brain reveals multiple 1- to 2-cm ring-enhancing lesions in the right basal ganglia and frontal lobe with marked surrounding vasogenic edema causing a 4-mm midline shift. Serum *Toxoplasma gondii* IgG antibodies are positive.

Arrange the following clinical actions in the correct chronological sequence according to the standard management algorithm for this patient, assuming a complete lack of clinical or radiographic response to the first-line medical intervention.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first start empiric toxoplasmosis therapy, follow up with a repeat brain MRI in 10-14 days to check for response, perform a stereotactic brain biopsy when there is no improvement, test the tissue for EBV DNA to confirm lymphoma, and finally initiate high-dose methotrexate therapy.
In patients with advanced HIV (CD4 < 100 cells/mm³) presenting with multiple ring-enhancing brain lesions and positive Toxoplasma serology, the standard of care is to initiate an empiric trial of anti-Toxoplasma therapy (pyrimethamine, sulfadiazine, and leucovorin). Because these lesions frequently cause marked vasogenic edema and mass effect, early lumbar puncture is contraindicated due to the risk of cerebral herniation. The clinical and radiographic response to this empiric trial is assessed via repeat MRI in 10 to 14 days. If the lesions do not regress or if the patient worsens, the diagnosis of Toxoplasma encephalitis becomes highly unlikely. At this juncture, primary central nervous system lymphoma (PCNSL)—the second most common cause of ring-enhancing lesions in HIV—becomes the primary differential diagnosis. A stereotactic brain biopsy is then indicated to establish a definitive tissue diagnosis. In HIV patients, PCNSL is almost universally an AIDS-defining malignancy driven by Epstein-Barr virus (EBV), which can be identified in the biopsied tissue via PCR or in-situ hybridization. Upon confirmation of PCNSL, the first-line targeted treatment is systemic chemotherapy utilizing high-dose methotrexate.

Adım Adım Çözüm

1
Evaluate the patient's initial presentation and infectious risk profile.
The patient has advanced HIV, multiple ring-enhancing lesions, and positive Toxo serology, pointing to Toxoplasma encephalitis.
Toxoplasmosis is the most common cause of focal brain lesions in HIV patients with CD4 < 100 cells/mm³.
2
Determine the first therapeutic intervention.
Initiate empiric pyrimethamine, sulfadiazine, and leucovorin.
Immediate medical treatment is required. Brain biopsy and lumbar puncture are deferred initially due to the high probability of toxoplasmosis and contraindications (mass effect risk for herniation).
3
Establish the follow-up interval for the empiric trial.
Perform a repeat brain MRI in 10 to 14 days.
To determine if the empiric trial is successful. A complete lack of clinical or radiographic response strongly indicates an alternative diagnosis.
4
Identify the next procedural step for treatment failure.
Consult neurosurgery for a stereotactic brain biopsy.
Failure of empiric therapy shifts the most likely diagnosis to Primary Central Nervous System Lymphoma (PCNSL), which requires definitive tissue confirmation before starting chemotherapy.
5
Confirm the alternative diagnosis pathologically.
Send biopsied tissue for EBV DNA testing.
PCNSL in immunocompromised patients is almost universally driven by Epstein-Barr virus (EBV).
6
Select the targeted therapy for the confirmed diagnosis.
Initiate high-dose methotrexate.
This is the first-line systemic chemotherapy standard of care for Primary CNS Lymphoma.

Anahtar Kavram

Algorithm for differentiating and managing Toxoplasma encephalitis versus Primary Central Nervous System Lymphoma in patients with advanced HIV.
Soru 4574Soru →

Evaluate the following clinical scenarios of infants presenting with hyperbilirubinemia. Pair each clinical description with the most appropriate underlying diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 4-week-old infant presents with worsening icterus, acholic stools, and hepatomegaly. Lab work shows elevated direct bilirubin.
An exclusively breastfed 14-day-old infant is thriving and gaining weight appropriately. Total bilirubin is mildly elevated with a normal direct fraction.
A 3-day-old infant, exclusively breastfed, has lost 11% of birth weight and has decreased stooling. Total bilirubin is elevated with a normal direct fraction.
A 16-hour-old infant develops visible jaundice. The mother is blood type O positive and the infant is A positive with a positive direct antiglobulin test.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches depend on the timing of jaundice onset, the infant's hydration and weight status, and whether the hyperbilirubinemia is conjugated (direct) or unconjugated (indirect).
Each diagnosis correlates with a unique clinical pattern. ABO incompatibility presents within 24 hours. Lactation failure presents within the first week with poor feeding and dehydration. Breast milk jaundice peaks in the second week in healthy infants. Biliary atresia uniquely presents with conjugated hyperbilirubinemia and acholic stools.

Adım Adım Çözüm

1
Analyze the timing of jaundice onset.
Jaundice in the first 24 hours is pathologic (e.g., ABO incompatibility). Jaundice in the first week accompanied by weight loss is lactation failure. Jaundice peaking in the second week in a thriving infant is breast milk jaundice.
The chronologic timeline restricts the differential diagnosis for neonatal hyperbilirubinemia.
2
Evaluate the bilirubin fractionation.
Elevated direct bilirubin (conjugated) points to hepatobiliary pathology like biliary atresia, whereas elevated indirect bilirubin (unconjugated) suggests physiologic, breastfeeding-related, or hemolytic causes.
Conjugated hyperbilirubinemia is always pathologic, requiring prompt anatomic and functional investigation of the biliary tree.

Anahtar Kavram

Differential diagnosis of neonatal hyperbilirubinemia based on presentation timing, hydration status, and conjugated versus unconjugated bilirubin predominance.
Soru 4575Soru →

Match each of the following patient presentations, which are characterized by specific acid-base and electrolyte derangements (Left), with the precise underlying cellular or transporter defect (Right).

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 24-year-old female presents with chronic fatigue. Laboratory evaluation reveals a K+K^+ of 2.8 mEq/L, Mg2+Mg^{2+} of 1.2 mEq/L, and HCO3−HCO_3^- of 32 mEq/L. Her blood pressure is 110/70 mm Hg. A 24-hour urine collection shows a calcium-to-creatinine ratio of 0.05.
A 19-year-old male is evaluated for severe, treatment-resistant hypertension with a blood pressure of 175/110 mm Hg. Laboratories demonstrate a K+K^+ of 2.6 mEq/L and HCO3−HCO_3^- of 31 mEq/L. Both plasma renin activity and serum aldosterone concentrations are markedly suppressed.
A 38-year-old female presents with recurrent nephrolithiasis and is found to have bilateral medullary nephrocalcinosis on imaging. Laboratories show a K+K^+ of 3.1 mEq/L, Cl−Cl^- of 112 mEq/L, and HCO3−HCO_3^- of 16 mEq/L. Her fasting morning urine pHpH is 6.8.
A 55-year-old male with multiple myeloma presents with bone pain. Laboratories reveal a K+K^+ of 2.9 mEq/L and HCO3−HCO_3^- of 15 mEq/L with a normal serum anion gap. Urinalysis demonstrates significant glycosuria despite a simultaneous serum glucose of 90 mg/dL.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align the hypocalciuric normotensive patient with the DCT NCCT defect, the hypertensive patient with suppressed aldosterone to ENaC hyperactivity, the patient with nephrocalcinosis and alkaline urine to impaired alpha-intercalated cell H+ secretion, and the multiple myeloma patient with normoglycemic glycosuria to proximal convoluted tubule dysfunction.
Arriving at the correct diagnosis for each tubulopathy requires synthesizing the acid-base status, serum electrolytes, blood pressure, and specific urinary findings (calcium excretion, glucose, pH). Once the clinical syndrome is accurately identified, it maps precisely to a unique anatomical location and molecular transporter defect within the nephron.

Adım Adım Çözüm

1
Evaluate the patient presenting with normotension, hypokalemia, metabolic alkalosis, and hypocalciuria.
Identify Gitelman syndrome, which maps to a defect in the distal convoluted tubule (NCCT).
The unique combination of salt-wasting (hypokalemia, alkalosis) with normotension and low urine calcium uniquely points to a distal convoluted tubule defect rather than a loop of Henle defect (Bartter syndrome).
2
Evaluate the patient with severe hypertension, hypokalemic metabolic alkalosis, and suppressed renin/aldosterone.
Identify Liddle syndrome, which maps to a gain-of-function mutation in ENaC.
If aldosterone is suppressed despite features of hyperaldosteronism, the defect must be constitutive activation of the downstream sodium channel in the collecting duct.
3
Evaluate the patient with a non-anion gap metabolic acidosis, hypokalemia, nephrocalcinosis, and fasting urine pH of 6.8.
Identify Type 1 (distal) RTA, which maps to defective H+ secretion by alpha-intercalated cells.
The inability to acidify urine below a pH of 5.5, combined with calcium phosphate stones, localizes the defect precisely to the distal nephron's proton pumps.
4
Evaluate the patient with multiple myeloma presenting with non-anion gap metabolic acidosis, hypokalemia, and normoglycemic glycosuria.
Identify Fanconi syndrome (Type 2 proximal RTA), which maps to generalized proximal convoluted tubule dysfunction.
Glycosuria in the absence of hyperglycemia implies a failure of the proximal tubule's Na+/glucose cotransporter, which often accompanies a failure to reabsorb bicarbonate in Fanconi syndrome.

Anahtar Kavram

Pathophysiology and localization of renal tubular defects, including renal tubular acidoses and inherited tubulopathies.
Tahmini Süre:3m 0s
Soru 4576Soru →

A 3232-year-old woman comes to the clinic due to progressive fatigue, weight loss, lightheadedness, and failure to resume her menses. Ten months ago, she delivered a healthy full-term infant. The delivery was complicated by severe postpartum hemorrhage requiring an emergency blood transfusion and a brief admission to the intensive care unit. Following discharge, she was unable to produce breast milk. Her blood pressure is 88/5488/54 mmHg, and her pulse is 9292/min. Physical examination shows pale skin without hyperpigmentation and delayed relaxation of deep tendon reflexes. Laboratory studies show:

Laboratory TestResultReference Range
Serum sodium131131 mEq/L136−145136-145 mEq/L
Serum potassium4.24.2 mEq/L3.5−5.03.5-5.0 mEq/L
Thyroid-stimulating hormone (TSH)1.81.8 μ\muU/mL0.4−4.00.4-4.0 μ\muU/mL
Free thyroxine (T4)0.40.4 ng/dL0.9−2.40.9-2.4 ng/dL

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Measure morning serum cortisol levels

Cevap

Measure morning serum cortisol levels
The patient's history of massive postpartum hemorrhage followed by agalactorrhea, amenorrhea, and progressive fatigue is a classic presentation of Sheehan syndrome (postpartum pituitary necrosis). This condition causes panhypopituitarism, leading to multiple endocrine deficiencies. The laboratory results show central hypothyroidism (low free T4 with an inappropriately normal TSH). She also has symptoms and signs of secondary adrenal insufficiency (hypotension, hyponatremia, and fatigue). The most appropriate next step is to evaluate her adrenal axis by measuring morning serum cortisol. In any patient with combined adrenal and thyroid deficiency, it is an absolute rule that glucocorticoids must be evaluated and replaced BEFORE starting thyroid hormone replacement. Levothyroxine increases the basal metabolic rate and enhances the hepatic clearance of cortisol. If levothyroxine is given to a cortisol-deficient patient, it can rapidly precipitate a fatal acute adrenal crisis.

Adım Adım Çözüm

1
Identify the underlying diagnosis based on the clinical history and presentation.
The history of massive postpartum hemorrhage followed by agalactorrhea and amenorrhea indicates Sheehan syndrome (postpartum ischemic necrosis of the pituitary gland).
Severe blood loss causes profound hypotension, leading to hypoperfusion and infarction of the physiologically enlarged pituitary gland.
2
Interpret the laboratory findings in the context of suspected pituitary failure.
The patient has central hypothyroidism (low free T4 with inappropriately normal TSH) and suspected secondary adrenal insufficiency (hyponatremia and hypotension, but normal potassium).
The necrotic anterior pituitary fails to produce adequate TSH and ACTH. Aldosterone is preserved because it is regulated by the renin-angiotensin-aldosterone system, not ACTH.
3
Determine the correct sequencing of diagnostic and therapeutic interventions.
Adrenal function must be assessed with a morning serum cortisol level (or ACTH stimulation test) before any thyroid hormone is administered.
Administering levothyroxine increases the basal metabolic rate and hepatic clearance of cortisol. In a patient with unrecognized adrenal insufficiency, this can precipitate a life-threatening acute adrenal crisis.

Anahtar Kavram

In patients with panhypopituitarism (e.g., Sheehan syndrome), adrenal insufficiency must be evaluated and treated with glucocorticoids before initiating levothyroxine therapy to prevent an acute adrenal crisis.
Soru 4577Soru →

A hospital's antimicrobial stewardship and infectious diseases teams are reviewing several complex cases involving severe adverse drug events. Match each patient's clinical presentation of an antimicrobial-induced complication to the specific pharmacologic agent most likely responsible.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 54-year-old man receiving intravenous therapy for right-sided methicillin-resistant Staphylococcus aureus (MRSA) endocarditis develops new-onset fever, hypoxic respiratory failure, and diffuse pulmonary infiltrates with peripheral eosinophilia.
A 36-year-old woman treated with oral therapy for a polymicrobial diabetic foot infection presents to the emergency department with severe, sudden-onset posterior ankle pain and swelling that worsened after walking.
A 45-year-old man receiving high-dose prophylaxis for Pneumocystis jirovecii is noted to have asymptomatic hyperkalemia and an elevation in serum creatinine, though his true glomerular filtration rate remains unchanged.
A 68-year-old woman on long-term oral therapy for vancomycin-resistant Enterococcus (VRE) osteomyelitis develops bilateral stocking-glove sensory loss, visual changes, and new-onset thrombocytopenia.
A 72-year-old man with chronic kidney disease receiving intravenous therapy for Pseudomonas aeruginosa pneumonia develops sudden myoclonus, encephalopathy, and non-convulsive status epilepticus.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Eosinophilic pneumonia matches with Daptomycin. Achilles tendinopathy matches with Levofloxacin. Hyperkalemia and pseudo-kidney injury match with Trimethoprim-sulfamethoxazole. Myelosuppression and neuropathy match with Linezolid. Neurotoxicity and seizures match with Cefepime.
Each clinical vignette describes a hallmark adverse reaction to a specific antimicrobial agent used in serious infections. Daptomycin is known to cause acute eosinophilic pneumonia. Levofloxacin carries a black box warning for Achilles tendinopathy. Trimethoprim-sulfamethoxazole blocks ENaC channels causing hyperkalemia and inhibits creatinine secretion without true renal injury. Linezolid causes mitochondrial toxicity leading to cytopenias and neuropathy after prolonged use. Cefepime accumulates in renal failure, lowering the seizure threshold and causing distinct encephalopathy.

Adım Adım Çözüm

1
Analyze each clinical vignette to identify the underlying infection and the specific adverse pharmacological event.
Identified toxicities: eosinophilic pneumonia, tendinopathy, hyperkalemia with pseudo-AKI, prolonged-use mitochondrial toxicity, and neurotoxicity.
Accurate identification of the syndrome is required to link it to the offending agent.
2
Correlate the identified toxicities with the antimicrobial agents known to treat the specified infections.
Daptomycin causes eosinophilic pneumonia; Levofloxacin causes tendinopathy; TMP-SMX alters potassium and creatinine handling; Linezolid causes neuropathy and cytopenias; Cefepime causes neurotoxicity in renal failure.
Antimicrobial stewardship requires monitoring for highly specific, high-yield adverse effects associated with targeted therapies.
3
Pair each clinical presentation with its definitive causative agent based on pharmacodynamic toxicity profiles.
All five distinct clinical scenarios are correctly matched to their respective antimicrobial agents.
Finalizing the matches completes the clinical evaluation.

Anahtar Kavram

Recognizing classic and severe adverse pharmacological effects of commonly used targeted antimicrobial therapies.
Soru 4578Soru →

A 45-year-old man with a history of poorly controlled type 2 diabetes mellitus is brought to the emergency department due to confusion, nausea, and abdominal pain for the past 2 days. He has missed his last several doses of insulin. His temperature is 37.1°C (98.8°F), blood pressure is 100/65 mm Hg, pulse is 112/min, and respirations are 24/min. Physical examination shows dry mucous membranes and a fruity breath odor.

Laboratory studies show:

Laboratory TestResult
Sodium142 mEq/L
Potassium4.8 mEq/L
Chloride102 mEq/L
Bicarbonate14 mEq/L
Blood urea nitrogen25 mg/dL
Creatinine1.4 mg/dL
Glucose450 mg/dL

What is this patient's serum anion gap (in mEq/L)?

Cevabı ve açıklamayı göster

Cevap: 26

Cevap

26
The serum anion gap is calculated using the formula: Anion Gap=Na+−(Cl−+HCO3−)\text{Anion Gap} = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-). Using the patient's laboratory values, the calculation is 142−(102+14)=142−116=26142 - (102 + 14) = 142 - 116 = 26 mEq/L. A normal anion gap is typically between 8 and 12 mEq/L. This patient has an elevated anion gap of 26 mEq/L, consistent with high anion gap metabolic acidosis secondary to diabetic ketoacidosis.

Adım Adım Çözüm

1
Identify the formula for serum anion gap.
Anion Gap=Na+−(Cl−+HCO3−)\text{Anion Gap} = \text{Na}^+ - (\text{Cl}^- + \text{HCO}_3^-)
This is the standard formula used to evaluate the etiology of metabolic acidosis.
2
Extract the necessary serum electrolyte values from the vignette.
Na+=142\text{Na}^+ = 142, Cl−=102\text{Cl}^- = 102, HCO3−=14\text{HCO}_3^- = 14.
These are the three variables required for the calculation.
3
Perform the calculation.
142−(102+14)=142−116=26142 - (102 + 14) = 142 - 116 = 26.
To determine the exact numerical value of the anion gap.

Anahtar Kavram

Calculation of the serum anion gap in the evaluation of metabolic acidosis
Soru 4579Soru →

Match each classic urinalysis sediment finding with its most likely associated renal pathology.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Muddy brown granular casts
Red blood cell casts
White blood cell casts
Fatty casts with a 'Maltese cross' appearance
Broad, waxy casts

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Muddy brown granular casts match with Acute tubular necrosis. Red blood cell casts match with Acute glomerulonephritis. White blood cell casts match with Acute interstitial nephritis. Fatty casts match with Nephrotic syndrome. Broad, waxy casts match with Advanced chronic kidney disease.
Each type of urinary cast has a specific mechanism of formation that correlates with a distinct pathophysiology. Muddy brown casts reflect tubular necrosis. RBC casts indicate glomerular basement membrane injury. WBC casts indicate tubulointerstitial inflammation. Fatty casts indicate lipiduria from nephrotic syndrome. Broad waxy casts indicate dilated tubules in chronic kidney disease.

Adım Adım Çözüm

1
Identify the etiology of muddy brown granular casts.
Associated with acute tubular necrosis (ATN).
Ischemia or nephrotoxins cause necrosis of tubular epithelial cells, which slough off and form these characteristic casts.
2
Identify the etiology of red blood cell (RBC) casts.
Associated with acute glomerulonephritis.
RBCs escape through a damaged glomerular basement membrane and get trapped in Tamm-Horsfall mucoprotein in the tubules.
3
Identify the etiology of white blood cell (WBC) casts.
Associated with acute interstitial nephritis or pyelonephritis.
Inflammation of the interstitium and tubules leads to WBC exudation and cast formation.
4
Identify the etiology of fatty casts.
Associated with nephrotic syndrome.
Massive proteinuria stimulates hepatic lipoprotein synthesis, leading to hyperlipidemia and lipiduria, forming fatty casts.
5
Identify the etiology of broad, waxy casts.
Associated with advanced chronic kidney disease.
Chronic kidney disease leads to tubular dilation and hypertrophy; slow urine flow allows casts to form and become waxy.

Anahtar Kavram

Classic urinalysis cast findings and their specific renal etiologies
Soru 4580Soru →

A 5454-year-old woman is evaluated in the ambulatory care clinic for progressive lethargy and generalized weakness over the past six months. She states she feels persistently cold even during warm weather and has been struggling with constipation. Over the same period, she has been involved in several minor motor vehicle collisions, which she attributes to "not seeing cars coming from the side." Physical examination reveals pale, dry skin, puffiness around the eyes, and a delayed relaxation phase of the deep tendon reflexes. Confrontational visual field testing demonstrates decreased peripheral vision bilaterally.

Laboratory studies reveal:
Hemoglobin: 11.211.2 g/dL
Thyroid-stimulating hormone (TSH): 1.81.8 μ\mu U/mL (Normal: 0.40.4-4.04.0 μ\mu U/mL)
Free thyroxine (T4): 0.50.5 ng/dL (Normal: 0.90.9-1.71.7 ng/dL)

Which of the following is the most likely underlying mechanism for this patient's laboratory findings?

Cevabı ve açıklamayı göster

Cevap: Compression of anterior pituitary thyrotrophs

Cevap

Compression of anterior pituitary thyrotrophs
The correct answer is compression of anterior pituitary thyrotrophs. This patient presents with overt clinical signs of hypothyroidism paired with a low free thyroxine (T4) level and an inappropriately normal thyroid-stimulating hormone (TSH) level. This laboratory pattern indicates central (secondary) hypothyroidism. The presence of a bitemporal visual field deficit (frequently bumping into doorframes on the sides) confirms the presence of a mass in the sella turcica, such as a non-functioning pituitary macroadenoma. This mass expands upward to compress the optic chiasm and compresses the surrounding normal pituitary tissue, leading to decreased production of anterior pituitary hormones, including TSH.

Adım Adım Çözüm

1
Interpret the thyroid function tests.
The patient has a low free T4 and an inappropriately normal TSH.
Identifying that the TSH is not elevated in the setting of low T4 isolates the pathology to the hypothalamus or pituitary gland (central hypothyroidism).
2
Correlate laboratory findings with physical examination signs.
The patient exhibits bitemporal hemianopsia (decreased bilateral peripheral vision) alongside central hypothyroidism.
The anatomical proximity of the optic chiasm to the pituitary gland indicates that a sellar mass (e.g., macroadenoma) is compressing both structures.

Anahtar Kavram

Central (Secondary) Hypothyroidism
Tahmini Süre:1m 30s
ÖncekiSayfa 229 / 414Sonraki
Tüm alıştırma soruları — USMLE Step 2 CK | Examkin